ARCHIVES

Wiernik Loses Post At Einstein Following Unauthorized Trials

This article is from The Cancer Letter archive.

Vol. 19 No. 43 | November 5, 1993

Download PDF Visit The Full Archive

Related Articles

April issue of Business & Regulatory Report included (8 additional pages).

April 30, 2004

NCI To Offer Expanded Access To Oxaliplatin

May 31, 2002

Reinventing NCI: Rimer Says Report Consistent with Her Goals For DCCPS

October 17, 1997

In Brief: Rhoads Renamed Cancer Advisory Board Chairman; L-B’s Frederick Contract Renewed For $12 Million

June 28, 1974

NCI Program Develops Bioinformatics Tool To Design Cancer Drugs

September 13, 2002

Funding Opportunities.

April 12, 2002